Phage Therapy at the Crossroads Between Clinical Promise and Regulatory Challenge. [PDF]
Gallina A +5 more
europepmc +1 more source
Possible manufacture of test allergens in public pharmacies for the diagnosis of type I allergies: Legal aspects. [PDF]
Jost R +18 more
europepmc +1 more source
Advice to the US FDA to Allow US Pharmacopeia to Create Biological Product Specifications (BPS) to Remove Side-by-Side Analytical Comparisons of Biosimilars with Reference Products. [PDF]
Niazi SK.
europepmc +1 more source
Danish ban on Ashwagandha: Truth, evidence, ethics, and regulations. [PDF]
Patwardhan B +4 more
europepmc +1 more source
Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations. [PDF]
Jambon A +6 more
europepmc +1 more source
Clinical nuclear medicine applications of zirconium-89 immuno-PET: a comprehensive review from a radiopharmaceutical perspective. [PDF]
Dubois J +6 more
europepmc +1 more source
Chemistry, manufacturing, and controls for live microbial products: addressing classification challenges and enhancing process validation. [PDF]
Slijkerman R +5 more
europepmc +1 more source
Dietary Supplement Adulteration: Laboratory Approaches to Risk Mitigation. [PDF]
Ma C +4 more
europepmc +1 more source
Development of an automated method for in-house production of sodium 18F-fluoride for injection: process validation as a step toward routine clinical application. [PDF]
Atanasova Lazareva M +7 more
europepmc +1 more source

